PURE Bioscience, Inc.
PURE · OTC
7/31/2025 | 7/31/2024 | 7/31/2023 | 7/31/2022 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $334 | $0 | $1 | $3 |
| Short-Term Investments | $0 | $0 | $0 | $0 |
| Receivables | $474 | $0 | $0 | $0 |
| Inventory | $141 | $0 | $0 | $0 |
| Other Curr. Assets | $98 | $0 | $0 | $0 |
| Total Curr. Assets | $1,047 | $1 | $2 | $4 |
| Property Plant & Equip (Net) | $11 | $0 | $0 | $1 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $0 | $0 | $0 | $0 |
| Long-Term Investments | $0 | $0 | $0 | $0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $0 | $0 | -$0 | -$1 |
| Total NC Assets | $11 | $0 | $0 | $1 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $1,058 | $1 | $2 | $4 |
| Liabilities | – | – | – | – |
| Payables | $784 | $1 | $0 | $0 |
| Short-Term Debt | $0 | $0 | $0 | $0 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $0 | $0 | $0 |
| Other Curr. Liab. | $154 | $0 | $0 | $0 |
| Total Curr. Liab. | $938 | $1 | $1 | $1 |
| LT Debt | $5,236 | $3 | $1 | $0 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $0 | $0 | $0 | $0 |
| Total NC Liab. | $5,236 | $3 | $1 | $0 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $0 | $0 | $0 | $0 |
| Total Liabilities | $6,174 | $4 | $2 | $1 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $1,119 | $1 | $1 | $1 |
| Retained Earnings | -$138,994 | -$137 | -$133 | -$129 |
| AOCI | $0 | $0 | $0 | -$0 |
| Other Equity | $132,759 | $133 | $132 | $132 |
| Total Equity | -$5,116 | -$3 | $0 | $4 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $1,058 | $1 | $2 | $4 |
| Net Debt | $4,902 | $3 | -$0 | -$3 |